Arkadios Wealth Advisors Has $227,000 Stock Position in Sanofi (NASDAQ:SNY)

Arkadios Wealth Advisors grew its holdings in Sanofi (NASDAQ:SNY) by 19.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,709 shares of the company’s stock after purchasing an additional 751 shares during the period. Arkadios Wealth Advisors’ holdings in Sanofi were worth $227,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Northwest Investment Counselors LLC bought a new stake in Sanofi in the third quarter valued at approximately $29,000. Concord Wealth Partners raised its stake in Sanofi by 157.8% in the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after acquiring an additional 363 shares during the period. Fortitude Family Office LLC lifted its holdings in Sanofi by 708.6% during the 3rd quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after purchasing an additional 659 shares during the last quarter. Sunbelt Securities Inc. boosted its position in Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after purchasing an additional 313 shares during the period. Finally, Versant Capital Management Inc acquired a new position in shares of Sanofi in the fourth quarter valued at $54,000. Institutional investors own 14.04% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th.

Sanofi Stock Up 0.9 %

Shares of NASDAQ SNY opened at $51.98 on Friday. The stock has a market capitalization of $131.92 billion, a P/E ratio of 26.52, a PEG ratio of 1.19 and a beta of 0.57. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00. Sanofi has a 52 week low of $45.22 and a 52 week high of $58.97. The stock’s fifty day moving average is $48.61 and its 200 day moving average is $52.16.

Sanofi (NASDAQ:SNY) last released its quarterly earnings data on Friday, October 25th. The company reported $1.57 earnings per share for the quarter, beating the consensus estimate of $0.22 by $1.35. The business had revenue of $13.44 billion for the quarter, compared to analyst estimates of $16.59 billion. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. Sanofi’s revenue was up 12.3% compared to the same quarter last year. During the same period last year, the firm posted $2.55 earnings per share. Sell-side analysts forecast that Sanofi will post 3.82 earnings per share for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.